PA
NIU

PharVision Advisers’s Niu Technologies NIU Stock Holding History

PharVision Advisers’s Portfolio NIU Stock Details NIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-119,283
Closed -$361K – 462
2025
Q4 		$361K Buy
+119,283
New +$462K 0.18% 164

Other funds holding NIU

VIM
Vinva Investment Management Sydney, Australia $8.07B AUM 29.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PharVision Advisers's NIU Position: Q1 2026 in Review

PharVision Advisers sold out of Niu Technologies (NIU) in Q1 2026, closing a stake of 119,283 shares — an estimated $361K sold.

PharVision Advisers first reported a position in NIU in Q4 2025 and held it in 1 quarter. The position peaked at $361K in Q4 2025. 49 funds tracked by Wall St. Rank hold NIU as of Q1 2026.

  • PharVision Advisers reported no remaining Niu Technologies position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 119,283 Niu Technologies shares in Q1 2026, an estimated $361K.
  • PharVision Advisers first reported a position in Niu Technologies in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Niu Technologies position peaked at $361K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Niu Technologies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.